Quality and Analytical Testing
How Do You Read an HPLC Chromatogram for a Peptide?
Quick answer
Read an HPLC chromatogram from the method first, then the picture. The x-axis is retention time in minutes and the y-axis is absorbance in mAU, usually at 214 or 220 nm for a peptide. Purity is the main peak area divided by the total integrated area, so the gradient, wavelength and integration threshold decide the number as much as the chemistry does.
Key facts at a glance
| Typical column | C18 reversed-phase, 2.1–4.6 mm internal diameter, 3–5 µm particles, 100–300 Å pores |
|---|---|
| Typical detection | 214 nm or 220 nm for the peptide backbone; 280 nm for Trp, Tyr and to a lesser extent Cys |
| Typical mobile phase | Water and acetonitrile, each with 0.1% trifluoroacetic acid |
| Typical gradient | 5–60% or 10–70% organic over 20–40 minutes, at 0.5–1.0 mL/min |
| Purity calculation | Main peak area ÷ total integrated peak area × 100 |
| Common failure | A purity figure quoted without column, gradient, wavelength and integration threshold |
What the axes, the baseline and the first peaks show
The horizontal axis is retention time in minutes, measured from injection. The vertical axis is absorbance in milli-absorbance units at the wavelength the detector was set to. A peptide chromatogram normally starts with a void-volume disturbance, where salts, the injection solvent and unretained material come through, followed by the peptide peaks, followed by a rise in baseline as the organic proportion of the mobile phase increases.
Two features are easy to misread. The injection peak at the start is not an impurity in the usual sense; it is solvent and buffer, and it is normally excluded from the purity calculation. The gradient rise at the end is baseline drift, not a broad impurity, although a genuine late-eluting peak can sit on top of it. The integration report should show which peaks were counted, because the denominator of the purity calculation is the sum of the peaks the software accepted.
Why peptides are detected at 214 nm rather than 280 nm
The peptide bond absorbs strongly between roughly 190 and 230 nm, so detection at 214 or 220 nm responds to the backbone itself. That makes the response broadly comparable across sequences, which is what you want when estimating how much of the UV-absorbing material is the target molecule.
At 280 nm only aromatic side chains absorb appreciably: tryptophan strongly, tyrosine moderately, phenylalanine weakly, and cysteine through its disulfide. A peptide with no aromatic residues is nearly invisible at 280 nm, so a chromatogram run at that wavelength may show almost nothing even for a good sample. The practical convention is to run at 214 nm for purity and to use 280 nm as a confirmation channel when the sequence contains Trp or Tyr, or when a co-eluting solvent artefact needs to be distinguished from peptide. A diode-array detector allows both, and the ratio of the two signals gives a rough check on peak identity.
How area percent is calculated, and what it hides
Area percent is the target peak area divided by the sum of all integrated peak areas, multiplied by 100. The definition is simple; the inputs are not.
| Term | What it tells you |
|---|---|
| Retention time | Where the peak eluted. Useful for identity only when compared with a standard run under the same method. |
| Peak area | Integrated absorbance over time. Proportional to amount for a given compound at a given wavelength. |
| Area percent | Relative share of integrated UV signal. Not a mass fraction and not a peptide content. |
| Total peak area | The denominator. Changes if the integration threshold, run length or baseline handling changes. |
| Resolution | Separation between two peaks. Low resolution means two compounds may be integrated as one. |
| Tailing factor | Peak symmetry. Values above about 2 suggest secondary interactions or column problems. |
| Signal-to-noise | Whether a small peak is real or baseline noise, and therefore whether it belongs in the denominator. |
Because UV response per unit mass differs between sequences, area percent is not mass percent. An impurity with more aromatic residues than the target can be over-represented; a Gly-rich truncation can be under-represented. The figure is a relative estimate of UV-absorbing material, which is useful and comparable only within one method.
Reading peak shape: shoulders, fronting and late impurities
A shoulder on the leading or trailing edge of the main peak is the most informative feature in a peptide chromatogram. It usually represents a closely related sequence: a deletion, a truncation, a missed coupling, or an incompletely deprotected residue. If the shoulder is integrated separately, purity drops honestly. If it is integrated with the main peak, purity rises and the impurity is hidden inside the number.
Fronting, where the peak leans forward, often indicates column overload or a mismatch between sample solvent and mobile phase. Tailing, where it drags, is commonly caused by interaction between basic residues such as arginine, lysine and histidine and residual silanol groups on the silica. Late-eluting peaks are usually more hydrophobic impurities: protected fragments, aggregation, or truncated sequences with exposed aromatic residues. A short run that ends before those peaks elute will report a cleaner product than a long run on the same vial, which is why the gradient table belongs on the report.
How TFA ion-pairing changes retention and peak shape
Trifluoroacetic acid at about 0.1% in both aqueous and organic mobile phases is the default for peptide reversed-phase chromatography. It protonates basic residues and pairs with them, which improves peak shape and gives the shallow, predictable retention that peptide methods depend on. Change the acid and the chromatography changes with it: formic acid produces different selectivity, and phosphate buffers can resolve what TFA cannot.
The practical consequence is that retention times are not transferable between laboratories without the full method. Even the same method run with a different lot of TFA, a different C18 batch, or a column that has seen 500 injections can shift a peak by several tenths of a minute. That is why identity by retention time alone is weak evidence and why a mass measurement is still required. Gradient performance and system suitability are described in general terms in Ph. Eur. 2.2.29 and 2.2.46, which set out how resolution, repeatability and peak symmetry should be assessed.
What a clean chromatogram does not prove
A single symmetrical peak at 214 nm is a good sign, not a proof of identity. It cannot distinguish the target sequence from a sequence isomer of the same length, an epimerised residue, or a peptide with the same hydrophobicity and a different order of residues. Those questions need mass spectrometry and, for isomers, sometimes peptide mapping or amino acid analysis.
Nor does the chromatogram measure anything that does not absorb at the detection wavelength. Water, trifluoroacetate, inorganic salts and many residual solvents are invisible to it. And it does not measure peptide content, because area percent is a ratio of UV signals. A chromatogram is one of three measurements a purity claim needs, alongside identity by mass and content by assay; the combination is explained in how peptide purity is tested.
Method details to look for on the report
- Column: manufacturer, chemistry, dimensions, particle size and pore size. A C18 is not interchangeable with a C8 or a phenyl column.
- Mobile phase: exact composition, including acid concentration and whether it is v/v or w/v.
- Gradient: starting and ending organic percentage, ramp time, hold time and re-equilibration.
- Flow rate and temperature. Both shift retention, and column ovens are not always used.
- Injection: volume, sample concentration and diluent. Overloading flattens the main peak and hides small impurities.
- Detection: wavelength, bandwidth and whether a reference wavelength was subtracted.
- Integration: threshold, minimum area, and whether the solvent front and system peaks were excluded.
- System suitability: resolution, tailing factor and repeatability from the run, not from a generic certificate.
If a report omits these, the purity figure is not reproducible and cannot be compared with another supplier. MOL Changes reports the method alongside the chromatogram for every batch, and the reading conventions above are the ones we use when we review release data. The document that carries these results is described in what a peptide COA must contain.
Frequently asked questions
What does a single peak on an HPLC chromatogram mean?
It means that, under that method and at that wavelength, only one UV-absorbing species was resolved. It does not prove the sequence is correct, because isomers and closely related peptides can co-elute, and it says nothing about water, salts or counter-ions that do not absorb at 214 nm.
Why is peptide purity measured at 214 nm?
The peptide bond absorbs strongly near 200 to 220 nm, so 214 nm responds to the backbone of every residue rather than to particular side chains. That gives a more sequence-independent view of how much UV-absorbing material is present than 280 nm, which only sees aromatic residues.
Why does my peptide show two peaks?
Common causes are a deletion or truncation sequence, incomplete deprotection, oxidation of methionine or tryptophan, and partial disulfide formation. A shoulder rather than a fully resolved peak often means the impurity differs by one or two residues and is close in hydrophobicity.
Is 95% HPLC purity good for a peptide?
For most research applications, yes. It is a normal release specification for custom synthesis, and 98%+ is achievable for many sequences. What matters more is whether the method was sensitive enough to detect the impurities that affect your assay, and whether the chromatogram is supplied so you can judge.
What is a good retention time for a peptide?
There is no universal value; it depends on the gradient and the sequence. A practical target is elution in the middle third of the gradient, well away from the solvent front and from the column wash. Peaks eluting very early are poorly retained; peaks eluting only at high organic are hard to separate from hydrophobic impurities.
Can I compare HPLC purity between two suppliers?
Only if the methods match. Column chemistry, gradient length, wavelength and integration threshold all change the result. A 98% figure from a 12-minute screening gradient is not equivalent to 95% from a 60-minute high-resolution method, and the shorter method may simply not see the impurities.
Sources and scope
This answer is based on peer-reviewed peptide chemistry and analytical literature, pharmacopoeial requirements (USP <503>, Ph. Eur. 2.2.29 and 2.2.46), FDA and EMA guidance on peptide drug substances, and MOL Changes in-house synthesis and testing data. Product statements describe research-grade peptides supplied for laboratory and manufacturing use. They are not medical advice and are not a substitute for clinical judgement.
